Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-3.04%EBITDA Margin
VS
Market
Sector
Industry
History
$ 10.43Close
$ 4.84 - $ 18.61 52-Week Range
Ticker Information
Ticker
NEOCompany Name
NEOGENOMICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQNEOGENOMICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NEO - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -20.98M | -3.04% | $ 689.19M |
| 3/31/2025 | $ 8.02M | 1.19% | $ 672.36M |
| 12/31/2024 | $ 7.42M | 1.12% | $ 660.57M |
| 9/30/2024 | $ 21.02M | 3.26% | $ 644.12M |
| 6/30/2024 | $ 13.06M | 2.08% | $ 628.25M |
| 3/31/2024 | $ 1.33M | 0.22% | $ 610.66M |
| 12/31/2023 | $ -8.37M | -1.42% | $ 591.64M |
| 9/30/2023 | $ -33.48M | -5.82% | $ 574.8M |
| 6/30/2023 | $ -49.17M | -8.91% | $ 551.62M |
| 3/31/2023 | $ -61.34M | -11.58% | $ 529.78M |
Key Performance Insights, Last 5 Years
- NEOGENOMICS INC's latest trailing twelve months (TTM) EBITDA % stands at 6.69%.
- Over the past 5 years, NEOGENOMICS INC's average EBITDA % has been 0.23%.
- The median EBITDA % for NEOGENOMICS INC during this period was 1.16%
- NEOGENOMICS INC reached its highest EBITDA % over the past 5 years at 23.14%.
- The lowest EBITDA % recorded by NEOGENOMICS INC in the same timeframe -19.28%
NEOGENOMICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for NEOGENOMICS INC is calculated as follows: EBITDA [ $ 28.47M ] / Revenues [ $ 425.32M ]
(=) EBITDA % [ 6.69% ] NEO - EBITDA Margin, Last 5 years
-19.28%
Minimum
Sep 30, 2022
23.14%
Maximum
Jun 30, 2021
0.23%
Average
1.16%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.13% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.13% |
| median | 14.72% |
| std | 26.88% |